fk 633 has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaida, T; Kozawa, O; Matsuno, H; Miyata, H; Niwa, M; Uematsu, T | 1 |
2 other study(ies) available for fk 633 and Thrombosis
| Article | Year |
|---|---|
Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
Topics: Animals; Carotid Arteries; Cricetinae; Dipeptides; Drug Implants; Fibrinolytic Agents; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Vascular Patency | 1997 |
FK 633. FR 144633.
Topics: Animals; Cardiovascular Agents; Cricetinae; Dipeptides; Dogs; Graft Occlusion, Vascular; Guinea Pigs; Humans; In Vitro Techniques; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1999 |